(Q33813321)

29 July 2017

1 reference

title

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. (English)

1 reference

29 July 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

He G

1

1 reference

29 July 2017

Massarella J

series ordinal

2

1 reference

29 July 2017

Ward P

series ordinal

3

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Clinical Pharmacokinetics

29 July 2017

published in

1 reference

29 July 2017

volume

37

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

471-484

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199937060-00003

29 July 2017

exact match

0 references

cites work

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

1 reference

12 December 2020

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

12 December 2020

The molecular biology of influenza virus pathogenicity

1 reference

12 December 2020

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

12 December 2020

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

12 December 2020

Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

The effectiveness of vaccination against influenza in healthy, working adults.

1 reference

12 December 2020

Disarming flu viruses

1 reference

12 December 2020

Influenza, influenza vaccine, and amantadine/rimantadine

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

1 reference

12 December 2020

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

1 reference

12 December 2020

Influenza virus pneumonia: pathogenesis, treatment, and prevention

1 reference

12 December 2020

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

12 December 2020

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

1 reference

12 December 2020

Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

French economic evaluations of influenza and influenza vaccination

1 reference

12 December 2020

Respiratory viruses and exacerbations of asthma in adults

1 reference

12 December 2020

Acute respiratory illness in the community. Frequency of illness and the agents involved

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

12 December 2020

10.2165/00003088-199937060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1013722712

0 references

1 reference